相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simvastatin enhances irinotecan-induced apoptosis in human non-small cell lung cancer cells by inhibition of proteasome activity
In Hae Park et al.
INVESTIGATIONAL NEW DRUGS (2011)
Tobacco Smoke Promotes Lung Tumorigenesis by Triggering IKKβ- and JNK1-Dependent Inflammation
Hiroyuki Takahashi et al.
CANCER CELL (2010)
Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines
Piyali Dasgupta et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
Primo N. Lara et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition
Sai-Hong Ignatius Ou et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
COPD and cancer mortality: the influence of statins
Y. R. B. M. van Gestel et al.
THORAX (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
The association between statins and cancer incidence in a veterans population
Wildon R. Farwell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients
Ricardo L. M. Duarte et al.
LUNG CANCER (2008)
Statins reduce the risk of lung cancer in humans* - A large case-control study of US veterans
Vikas Khurana et al.
CHEST (2007)
Management of small cell lung cancer - ACCP evidence-based clinical practice guidelines (2nd edition)
George R. Simon et al.
CHEST (2007)
Nuclear factor-κB (NF-κB) is frequently expressed in lung cancer and preneoplastic lesions
Ximing Tang et al.
CANCER (2006)
Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs
Emilie Roudier et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling
UK Khanzada et al.
ONCOGENE (2006)
Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome
ET Efuet et al.
CANCER RESEARCH (2006)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells
J Tsurutani et al.
CARCINOGENESIS (2005)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
Smoking and lung cancer survival - The role of comorbidity and treatment
CM Tammemagi et al.
CHEST (2004)
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
W Noda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis
SA Khuder
LUNG CANCER (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Lovastatin and simvastatin are modulators of the proteasome
C Wojcik et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)
分享论文
